Ortho Clinical Diagnostics Holdings Plc Stock Price, News & Analysis
Company Description
Ortho Clinical Diagnostics Holdings Plc (NASDAQ: OCDX) is a publicly traded diagnostics & research company in the Healthcare sector. The company has a market capitalization of $4.2B.
OCDX stock has declined 12.8% over the past year.
This page provides a comprehensive overview of OCDX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Ortho Clinical Diagnostics Holdings Plc (OCDX) stock. Over the past 12 months, the stock has lost 12.8%. At a market capitalization of $4.2B, OCDX is classified as a mid-cap stock with approximately 237.7M shares outstanding.
Latest News
Ortho Clinical Diagnostics Holdings Plc has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include earnings, covid-19, conferences. View all OCDX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
OCDX Company Profile & Sector Positioning
Ortho Clinical Diagnostics Holdings Plc (OCDX) operates in the Diagnostics & Research industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing OCDX often look at related companies in the same sector, including Sotera Health Co (SHC), GeneDx Holdings Corp (WGS), Radnet (RDNT), Guardant Health (GH), and Veracyte (VCYT). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate OCDX's relative position within its industry.